![Devyn Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Devyn Smith
Algemeen Directeur bij
Arbor Biotechnologies, Inc.
Profiel
Devyn M.
Smith is Chief Executive Officer at Arbor Biotechnologies, Inc. since 2021.
Dr. Smith is Chairman at Alliance for Regenerative Medicine since 2023.
Dr. Smith is Director at Aspect Biosystems Ltd. since 2022.
Dr. Smith is Director at Airna, Inc. Dr. Smith was Head-Business Operations & Strategy at Pfizer Inc. from 2009 to 2017.
Dr. Smith was Chief Operating Officer at Sigilon Therapeutics, Inc. Dr. Smith was Principal at Frankel Group LLC from 2003 to 2009.
Dr. Smith completed undergraduate studies at Brigham Young University, graduate studies at Idaho State University, and doctorate studies at Harvard Medical School.
Actieve functies van Devyn Smith
| Bedrijven | Functie | Begin |
|---|---|---|
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Voorzitter | 01-01-2023 |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Algemeen Directeur | 27-04-2021 |
Aspect Biosystems Ltd.
 Aspect Biosystems Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops bio printed tissue therapeutics | Directeur/Bestuurslid | 21-09-2022 |
Airna, Inc.
 Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Directeur/Bestuurslid | - |
Eerdere bekende functies van Devyn Smith
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01-01-2017 |
Frankel Group LLC | Corporate Officer/Principal | 01-08-2009 |
| SIGILON THERAPEUTICS, INC. | Operationeel Directeur | - |
Opleiding van Devyn Smith
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
79
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idaho State University
 Idaho State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Aspect Biosystems Ltd.
Aspect Biosystems Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops bio printed tissue therapeutics | Commercial Services |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Health Technology |
Frankel Group LLC | |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Commercial Services |
